Founded Year

2017

Stage

Series B | Alive

Total Raised

$70.62M

Last Raised

$60M | 4 yrs ago

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

-58 points in the past 30 days

About Lifebit

Lifebit operates as a company providing data intelligence platforms within the health sector. Its offerings include a federated genomics platform that allows for the analysis and integration of health data across various institutions and clouds, as well as tools for data harmonization, analytics, and target identification. Lifebit's services are used by various customers, including government entities, pharmaceuticals, health nonprofits, health systems, and data providers. It was founded in 2017 and is based in London, United Kingdom.

Headquarters Location

219 Kensington High Street Office 4

London, England, W8 6BD,

United Kingdom

Loading...

Lifebit's Product Videos

Lifebit's Products & Differentiators

    Lifebit CloudOS

    Lifebit CloudOS is an end-to-end data management and analysis platform for large-scale clinico-genomic data. From clinico-genomic data cleaning and data standardisation, to enabling research and clinical insights, Lifebit CloudOS handles the data life-cycle from end-to-end.

Loading...

Research containing Lifebit

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Lifebit in 1 CB Insights research brief, most recently on Dec 16, 2022.

Expert Collections containing Lifebit

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Lifebit is included in 5 Expert Collections, including Artificial Intelligence (AI).

A

Artificial Intelligence (AI)

16,578 items

Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.

D

Digital Health

12,122 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

D

Drug Discovery Tech Market Map

221 items

This CB Insights Tech Market Map highlights 220 drug discovery companies that are addressing 12 distinct technology priorities that pharmaceutical companies face.

D

Digital Health 50

150 items

2022's cohort of the most promising digital health startups transforming the healthcare industry. Winners were chosen based on several factors, including data submitted by the companies, proprietary Mosaic scores, company business models and momentum in the market.

H

HLTH 2025 Exhibitors

878 items

A look at the HLTH Vegas 2025 exhibitor list we’ve been building so your team can start scanning for relevant companies.

Latest Lifebit News

Lifebit Launches AI-Automated Airlock to Transform Compliance in Biomedical Results Data Exports

Oct 27, 2025

NEW YORK, NY, UNITED STATES, October 27, 2025 / EINPresswire.com / -- Lifebit Launches AI-Automated Airlock , the First AI-Powered Governance Solution for Biomedical Data Export Lifebit, the global leader in federated and AI-powered data intelligence platforms, today announced the release of its latest innovation: AI-Automated Airlock, the first solution in the industry to bring AI-driven automation, compliance, and transparency to the way researchers can export the results from their analysis over sensitive biomedical data. “Traditional results data export controls haven't evolved for the number of user scale and sensitivity of modern biomedical research. With the AI-Automated Airlock, we're introducing a completely new model — one where AI takes care of compliance automatically, so researchers can focus on discovery and authorities on increasing and enriching datasets. This is the first system in the industry that brings intelligence, trust, and transparency to every results data export.” — Maria Dunford, CEO of Lifebit In today's data-driven research landscape, securely managing results data exports from Trusted Research Environments and across regulatory frameworks is one of the most complex and risk-prone challenges. Manual oversight, inconsistent governance, and lack of visibility create delays, costs, and compliance vulnerabilities. Lifebit's AI-Automated Airlock changes that. It uses AI to automatically review, validate, and audit every results data export request, ensuring that sensitive patient data remains protected and compliant — without slowing down research. About the Solution The AI-Automated Airlock automates and secures the entire results data export lifecycle, integrating intelligent review workflows that guarantee full transparency and governance. By combining AI-powered export checks, governed approval processes, and real-time user feedback, the system delivers instant assurance that every results data export meets internal and regulatory standards. To learn more about the full functionality — including its governance design, compliance framework, and automation architecture — read the new AI-Automated Airlock whitepaper Why It Matters The AI-Automated Airlock is purpose-built to meet the needs of: Government and Research Institutions — maintaining transparency and trust in national data programs while enabling scale across 1,000s of users - Pharma and Biotech — ensuring compliant, auditable export of sensitive research data - Healthcare Systems — enabling secure, patient-centric data collaboration across environments By replacing manual oversight with AI-driven governance, the Airlock reduces risk, saves time, and sets a new benchmark for compliant data access at scale. Proven at Scale, Ready for the Future Lifebit's federated, AI-powered solutions are trusted by leading global institutions — including the NIH, Genomics England, 23andMe, and the Singapore Ministry of Health — managing over 275 million patient records across 30+ countries. “Federated, AI-powered, and compliance-first — this is the next generation of health data infrastructure,” added Dr. Maria Dunford. “The AI-Automated Airlock completes the secure foundation for global-scale biomedical collaboration.” About Lifebit Lifebit is the global leader in federated, secure, and AI-powered data intelligence platforms. We help governments, health systems, and pharmaceutical organizations unify, govern, and unlock biomedical data for real-world research, clinical impact, and life-saving discovery. Our platform is trusted by leading institutions — including the NIH, Genomics England, 23andMe, and the Singapore Ministry of Health — to securely manage and analyze over 275 million patient records across 30+ countries. With operations across the U.S., Canada, UK, Singapore, and Australia, Lifebit powers national precision medicine programs, enterprise data infrastructures, and AI-driven research initiatives worldwide. Nate Raine Lifebit email us here Visit us on social media: LinkedIn Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Lifebit Frequently Asked Questions (FAQ)

  • When was Lifebit founded?

    Lifebit was founded in 2017.

  • Where is Lifebit's headquarters?

    Lifebit's headquarters is located at 219 Kensington High Street, London.

  • What is Lifebit's latest funding round?

    Lifebit's latest funding round is Series B.

  • How much did Lifebit raise?

    Lifebit raised a total of $70.62M.

  • Who are the investors of Lifebit?

    Investors of Lifebit include Pentech, Tiger Global Management, Eurazeo, Beacon Capital Partners, Beacon Capital and 9 more.

  • Who are Lifebit's competitors?

    Competitors of Lifebit include Apheris and 7 more.

  • What products does Lifebit offer?

    Lifebit's products include Lifebit CloudOS and 1 more.

  • Who are Lifebit's customers?

    Customers of Lifebit include Genomics England, NIHR Cambridge Biomedical Research Centre/University of Cambridge, Danish National Genome Centre and Hong Kong Genome Institute.

Loading...

Compare Lifebit to Competitors

L
Latch Bio

Latch Bio provides a data infrastructure for biopharma research and development. Its offerings include a platform that features tools for visualizations, computing for analyses, and workflows. Its platform supports the research and development (R&D) process by enabling data centralization, metadata capture, and compliance standards, while also focusing on security. It was founded in 2021 and is based in San Francisco, California.

DNAnexus Logo
DNAnexus

DNAnexus operates as a platform for precision health, focusing on bioinformatics and genomics. The company provides a cloud-based solution for managing and analyzing multimodal omics data, equipped with bioinformatics tools and an environment for research and data sharing. DNAnexus serves sectors including pharmaceutical, biotech, clinical diagnostics, academic medical centers, commercial data businesses, and biobanks & population programs. It was founded in 2009 and is based in Mountain View, California.

R
Rhino Federated Computing

Rhino Federated Computing focuses on federated AI and data solutions within the technology sector. The company provides a platform that connects decentralized data sources for analytics and learning, addressing aspects of data security, privacy, and sovereignty. Rhino Federated Computing serves sectors such as healthcare, life sciences, public sector, and financial services. Rhino Federated Computing was formerly known as Salienc Technologies. It was founded in 2020 and is based in Boston, Massachusetts.

Owkin Logo
Owkin

Owkin is an AI biotechnology company that employs artificial intelligence to improve drug discovery and development in the biopharmaceutical sector. The company specializes in AI-based identification of new treatments, clinical trial optimization, and diagnostic tool creation, while ensuring patient privacy through federated learning techniques. Owkin serves the biopharma and academic research communities. It was founded in 2016 and is based in New York, New York.

T
TheraGenetics

theraGenetics is a personalized medicine diagnostics company developing pharmacogenetic tests to guide and improve the treatment of central nervous system (CNS) disorders; matching the medication to the patient.

E
Expression Diagnostics

XDx is a molecular diagnostics company focused on the discovery, development and commercialization of non-invasive gene expression testing in the areas of transplant medicine and autoimmunity. Per the company, they have developed a proprietary method of utilizing gene expression in blood that aims to provide a new tool for physicians to manage the care of heart transplant patients. The molecular expression technology developed and implemented by XDx in heart transplant patient management is currently being explored to assist with other diseases that involve the immune system.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.